Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) announced on Friday an agreement with the University of Virginia Health System, which sees an upgrade of its equipment.
It involves trading UVA Health's existing two research hyperpolarisers for two clinical-grade hyperpolariser systems provided by Polarean.
This will represent a significant step for UVA Health, which Polarean noted is advancing its position as a center of excellence for NIH grants, industry-sponsored trials, and clinical patient referrals for Xenon MRI.
The new clinical-grade systems are anticipated to enhance UVA Health's Xenon MRI research program and establish a foundation for clinical MRI capabilities.
Polarean said it expects to install the new systems later this year and will collaborate closely with UVA Health to ensure successful implementation.
"We are delighted to see UVA Health upgrade both of their hyperpolariser systems to clinical grade,” Polarean chief executive Christopher von Jako said in a statement.
“This milestone underscores the increasing adoption of Polarean's technology and the continued progress in our strategy to convert previously research-only centres to clinical-grade, in addition to establishing de novo sites.
He added: “We look forward to working with the team at UVA Health to ensure that their implementation of our Xenon MRI technology is successful as it continues to advance research and move into clinical use."